Falkman L., Sundin A., Skogseid B., Botling J., Bernardo Y., Wallin G., Zhang L., Welin S., Lase I., Mollazadegan K., & Crona J. (2024). Genetics-guided therapy in neuroendocrine carcinoma: response to BRAF- and MEK-inhibitors. Upsala Journal of Medical Sciences, 129(S1), e10660. https://doi.org/10.48101/ujms.v129.10660